Skip to main content

Cancer tests save lives! How new biomarkers from Jena are finding their way into global use.

 
Time
19:30 - 22:30 o'clock
Organizer
InfectoGnostics Forschungscampus Jena e.V.
Place
Jena
Adresse
Philosophenweg 7

In presentations at 7:30 p.m. and 10:30 p.m., Epitype researchers will explain how epigenetic tests can be used for the reliable early detection of cancer.

What exactly is epigenetics, and why can it be used in cancer diagnostics?

New biomarkers derived from epigenetics are a great tool for detecting cancer—or even the future development of cancer—at an early stage. 
The Jena-based company Epitype is working on this topic, with a focus on cervical cancer.

Epigenetic tests enable reliable cancer diagnoses

Human papillomaviruses (HPV) can cause cervical cancer or head and neck tumors. However, determining whether HPV-infected individuals will actually develop cancer requires precise diagnostics.Epitype GmbH, an InfectoGnostics campus partner, has developed a molecular test for this purpose that enables the reliable early detection of cervical cancer.

During the Long Night of Science, visitors will learn in a presentation how Epitype GmbH can detect epigenetic changes that occur specifically in cancer. 

 

 
Bild
Epitype-Forscherin im Labor
Epitype-Forscherin im Labor
, ©

Location

Sharing on social media